Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Dec 15, 2022; 14(12): 2329-2339
Published online Dec 15, 2022. doi: 10.4251/wjgo.v14.i12.2329
Published online Dec 15, 2022. doi: 10.4251/wjgo.v14.i12.2329
Figure 3 The effect of nucleus accumbens-1 on CD8+ T cells, myeloid-derived suppressor cells and regulatory T cells in the mouse colon cancer tumor microenvironment.
A: Flow cytometric detection of the effects of nucleus accumbens-1 (NAC-1), CD8+ T cells and MEK inhibitors on the expression of CD8+ T cells; B: Statistical analysis of CD8+ T-cell expression levels in each group; C: Flow cytometric detection of the effect of NAC-1 on the expression of myeloid-derived suppressor cells (MDSCs); D: Statistical analysis of the expression of MDSCs in each group; E: Flow cytometric detection of the effect of NAC-1 on the expression of regulatory T cell (Treg) cells; F: Statistical analysis of Treg expression in each group (aP < 0.05, bP < 0.01). NAC-1: Nucleus accumbens-1.
- Citation: Shen ZH, Luo WW, Ren XC, Wang XY, Yang JM. Expression of nucleus accumbens-1 in colon cancer negatively modulates antitumor immunity. World J Gastrointest Oncol 2022; 14(12): 2329-2339
- URL: https://www.wjgnet.com/1948-5204/full/v14/i12/2329.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i12.2329